Inhibitor Therapeutics, Inc. (INTI)
Develops cancer drugs that block abnormal cell growth in skin and other tissues.
$0.08-0.08%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+53.8%
The outlook
INTI is trading near the middle of its 52-week range at $0.08, with a mixed trend against its moving averages. Analyst coverage appears limited for this micro-cap stock. The StockGlow score sits at neutral, reflecting balanced sentiment without a clear directional lean.
What’s behind the score
Price trendMixed vs its moving averages
52-week range51% of the way from its 52-week low to high
Market cap
$13.8M
52-wk high
$0.12
52-wk low
$0.04
50-day avg
$0.08
200-day avg
$0.07
Trailing P/E
—